COVID19 Archives - Infectious Disease Advisor

Impact of Gender Inequities in Infectious Diseases and Internal Medicine

By

Jordana White

October 15, 2021

An update on where women stand in academia, in specialties such as infectious diseases and internal medicine, and the disproportionate impact of the COVID-19 pandemic on women.

COVID19

Outcomes of Treatment With Convalescent Plasma vs Standard Care in Patients With COVID-19

By

Jessica Nye, PhD

October 15, 2021

Investigators conducted a study that compared the risk for intubation or death with convalescent plasma vs standard care for the treatment of patients hospitalized with COVID-19.

COVID19

T-Cell and Humoral Response to SARS-CoV-2 Vaccine in Patients With MS on Ocrelizumab

By

Amit Akirov, MD

October 15, 2021

Researchers sought to determine the T-cell and antibody response to the SARS-CoV-2 vaccine in patients with multiple sclerosis treated with ocrelizumab, compared with healthy individuals.

The Denver City Council recently passed an ordinance to allow the nation’s first supervised injection site. The Colorado General Assembly must also render an approval. A bipartisan bill to allow the site narrowly failed in a Republican-controlled Senate in 2018, but party control will change in 2019, making its passage more likely.3 Meanwhile, cities including San Francisco and Philadelphia are moving forward with their own site plans, despite warnings from the US Justice Department. Whether in Denver, San Francisco, Philadelphia, or elsewhere, expect the first supervised injection site in the United States to open in the near future, and for a legal battle to follow.

COVID19, News

Breakthrough COVID-19 Risk Up for Patients With Substance Use Disorders

October 15, 2021

After controlling for lifetime comorbidities and adverse socioeconomic determinants of health, infection risk increased only for cannabis use disorder.